PGE1 is contraindicated in neonates with known hypersensitivity to the drug or any of its components. It should also be used cautiously in neonates with conditions where the patency of the ductus arteriosus is not beneficial and may even be harmful, such as certain types of pulmonary atresia without ventricular septal defect.
